| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A synthesized peptide derived from human Phospho-RIP3 (S232) was used as the immunogen for the Phospho-RIP3 (Ser232) antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
Phospho-RIP3 (Ser232) Antibody / RIPK3 is a anti-RIP3 (phospho-Ser232) Rabbit antibody Recombinant Rabbit Monoclonal clone 31R36 supplied in Liquid format. Recommended for workflows such as Western blot (WB) with listed reactivity in Mouse, Rat.
Key elements and design rationale
- Target: RIP3 (phospho site: Ser232)
- Antibody details: Rabbit, Recombinant Rabbit Monoclonal, clone 31R36, isotype Rabbit IgG
- Format: Liquid
- Applications (as listed): WB
Biological background
RIP3 functions as a core signaling kinase within the necrosome complex. Research using Phospho-RIP3 (Ser232) antibody has shown that phosphorylation at Ser232 is essential for RIP3 activation and subsequent recruitment of MLKL, the executioner protein of necroptosis. This phosphorylation serves as a molecular switch controlling progression of the necroptotic pathway.
Studies with Phospho-RIP3 (Ser232) antibody have revealed that necroptosis is triggered by tumor necrosis factor signaling, viral infection, and cellular stress conditions. RIP3 phosphorylation at Ser232 enables necrosome assembly, MLKL oligomerization, and disruption of plasma membrane integrity. This process releases intracellular contents that amplify inflammation and immune responses.
In disease contexts, dysregulated necroptosis contributes to pathology. Research using Phospho-RIP3 (Ser232) antibody has shown that excessive activation promotes tissue damage in conditions such as ischemia reperfusion injury, inflammatory bowel disease, and neurodegeneration. Conversely, insufficient necroptosis facilitates viral persistence and impaired immune clearance. These findings highlight RIP3 phosphorylation as a therapeutic target for modulating necroptotic signaling.
Phospho-RIP3 (Ser232) antibody is widely applied in western blotting, immunohistochemistry, and immunofluorescence. Western blotting distinguishes phosphorylated RIP3 from total levels, immunohistochemistry localizes activated necroptotic signaling in tissue, and immunofluorescence reveals subcellular distribution during necrosome formation. These applications make the antibody valuable in cell death research.
By providing validated Phospho-RIP3 (Ser232) antibody reagents,
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Quantifying post-translational regulation (including phosphorylation) alongside total protein levels.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Phospho-site readouts are condition-dependent and are often compared to total target levels when available.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Monoclonal antibodies provide a defined epitope recognition profile that can support consistent comparisons across experiments.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
